Segolene is the CEO and co-founder of Kantify. Kantify is a TechBio company, using AI to discover breakthrough therapies that change patients’ lives. Its cutting-edge AI platform, Sapian, has a proven track record of identifying novel therapeutic targets and small molecule drugs, and has recently disclosed its breakthrough model for off-target prediction of any small molecule. In addition to her role at Kantify, Segolene is the VP of the Board of the Brussels Lifetech Cluster, and she served as European Commission nominated Expert on the Global Partnership on AI until 2023. Segolene was nominated Young ICT Lady of Belgium, AI Personality of the Year in 2019, and was a winner of the InspiringFifty contest for women in tech. She also received the Business Trophy from the Cercle Montaigne.